BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,292,991 | -66.2% | 193,243 | -59.2% | 1.86% | -61.4% |
| Q2 2023 | $21,578,765 | +218.6% | 473,634 | +183.6% | 4.83% | +194.0% |
| Q1 2023 | $6,773,520 | -39.9% | 167,000 | -24.5% | 1.64% | -36.3% |
| Q4 2022 | $11,268,855 | +23.8% | 221,088 | +30.8% | 2.58% | +9.8% |
| Q3 2022 | $9,104,000 | -52.3% | 169,028 | -28.8% | 2.35% | -38.4% |
| Q3 2021 | $19,096,000 | +23.1% | 237,429 | +23.2% | 3.81% | +38.6% |
| Q2 2021 | $15,515,000 | -11.1% | 192,739 | -6.9% | 2.75% | -14.0% |
| Q1 2021 | $17,454,000 | -57.8% | 206,951 | -56.2% | 3.20% | -54.2% |
| Q3 2019 | $41,313,000 | +9.1% | 472,305 | +2.2% | 6.98% | +14.7% |
| Q2 2019 | $37,863,000 | +3.9% | 462,305 | +3.1% | 6.09% | +4.1% |
| Q1 2019 | $36,445,000 | +13.1% | 448,228 | -8.5% | 5.84% | +7.9% |
| Q4 2018 | $32,227,000 | -40.8% | 489,628 | -30.7% | 5.42% | -36.5% |
| Q3 2018 | $54,443,000 | +2.3% | 706,228 | -2.1% | 8.54% | -3.5% |
| Q2 2018 | $53,243,000 | +14.4% | 721,058 | +0.8% | 8.85% | +5.5% |
| Q1 2018 | $46,532,000 | +3.7% | 715,438 | +3.0% | 8.39% | +11.1% |
| Q4 2017 | $44,888,000 | -23.4% | 694,438 | -25.7% | 7.54% | -15.5% |
| Q3 2017 | $58,617,000 | -9.5% | 934,133 | -12.7% | 8.93% | -5.2% |
| Q2 2017 | $64,798,000 | +20.6% | 1,070,333 | +3.3% | 9.42% | +10.2% |
| Q1 2017 | $53,739,000 | +27.2% | 1,036,233 | +8.8% | 8.55% | +7.5% |
| Q4 2016 | $42,249,000 | -17.8% | 952,833 | -11.7% | 7.95% | -11.6% |
| Q3 2016 | $51,393,000 | +5.3% | 1,079,233 | +0.0% | 9.00% | -2.9% |
| Q2 2016 | $48,790,000 | -2.5% | 1,078,943 | -11.4% | 9.26% | -10.0% |
| Q1 2016 | $50,028,000 | +39.9% | 1,217,830 | +29.9% | 10.30% | +12.0% |
| Q4 2015 | $35,769,000 | +29.7% | 937,600 | +11.7% | 9.19% | +23.1% |
| Q3 2015 | $27,574,000 | -44.7% | 839,400 | +17.6% | 7.46% | -41.4% |
| Q2 2015 | $49,895,000 | +13.5% | 713,500 | +11.2% | 12.74% | +9.6% |
| Q1 2015 | $43,943,000 | +1.0% | 641,500 | +8.0% | 11.62% | +20.0% |
| Q4 2014 | $43,527,000 | +18.5% | 593,900 | +16.0% | 9.68% | +12.6% |
| Q3 2014 | $36,732,000 | -6.2% | 511,800 | -5.5% | 8.59% | -7.3% |
| Q2 2014 | $39,172,000 | -8.6% | 541,800 | -7.0% | 9.27% | -9.9% |
| Q1 2014 | $42,875,000 | +77.3% | 582,700 | +67.6% | 10.28% | +57.6% |
| Q4 2013 | $24,176,000 | +20.9% | 347,600 | +14.2% | 6.52% | +27.2% |
| Q3 2013 | $19,996,000 | +12.5% | 304,400 | +18.7% | 5.13% | -1.0% |
| Q2 2013 | $17,768,000 | – | 256,500 | – | 5.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |